Heterogeneous Postprandial Lipoprotein Responses in the Metabolic Syndrome, and Response to Fenofibrate Therapy

Author： Rosenson Robert   Helenowski Irene   Tangney Christine  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.5-6, 2010-12, pp. : 439-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fenofibrate and Metabolic Syndrome

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 2, 2010-06 ,pp. : 138-148

Bentham Science Publishers

Access to resources Recommend Favorite

Fenofibrate: A Review of its Use in Primary Dyslipidaemia, the Metabolic Syndrome and Type 2 Diabetes Mellitus

By Keating Gillian M.   Croom Katherine F.  

Drugs, Vol. 67, Iss. 1, 2007-01 ,pp. : 121-153

Adis International

Access to resources Recommend Favorite

Androgen deprivation therapy linked to metabolic syndrome

By  

Reactions Weekly, Vol. 1, Iss. 1118, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Androgen deprivation therapy linked to metabolic syndrome

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Anticoagulant Therapy in Pregnant Patients with Metabolic Syndrome: A Review

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 1, 2014-06 ,pp. : 47-63

Bentham Science Publishers

Access to resources Recommend Favorite